Why is Onyx Biotec falling/rising?

As of 29-Sep, Onyx Biotec Ltd is experiencing a decline in its stock price, currently at Rs 42.40, which reflects a decrease of Rs 2.55 or 5.67%. The stock has underperformed its sector by 5.81% today and is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. Additionally, the stock is close to its 52-week low, being only 2.59% away from Rs 41.3. Over the past week, the stock has dropped by 7.42%, and year-to-date, it has seen a significant decline of 28.74%. There is a notable decrease in investor participation, with delivery volume on September 26 falling by 90.08% compared to the 5-day average, indicating a lack of interest among investors.
In the broader market context, the Sensex has shown a decline of 2.25% over the past week, which is less severe than Onyx Biotec's performance. While the benchmark has gained 0.85% over the past month, Onyx Biotec's stock has dropped by 11.67% in the same period, highlighting its underperformance relative to the market. The stock's liquidity is deemed sufficient for trading, but the significant drop in delivery volume suggests that investor confidence is waning, contributing to the stock's downward trend. Overall, the combination of poor performance metrics, low investor engagement, and unfavorable comparisons to the benchmark indicates that Onyx Biotec is facing challenges that are driving its stock price lower.